Gunilla Ho slashedyer-Hansen

Title: Gunilla Ho Slashedyer-Hansen: Innovator in Cancer Research

Introduction

Gunilla Ho Slashedyer-Hansen is a notable inventor based in Gentofte, Denmark. She has made significant contributions to the field of cancer research through her innovative work in developing antibodies that target the urokinase plasminogen activator receptor (u-PAR). Her invention is crucial for advancing diagnostic and therapeutic approaches in oncology.

Latest Patents

Gunilla holds a patent titled "Antibodies and their use," which includes a monoclonal or polyclonal antibody directed against u-PAR or its variants. This patent outlines various applications of the antibody, including its use in ELISA for catching u-PAR, detection in blotting methods, and immunohistochemical analyses for cancer cell staining. The patent also discusses methods for inhibiting the interaction of pro-u-PA and active u-PA, thereby preventing cell surface plasminogen activation. These innovations are vital for improving cancer detection and treatment strategies.

Career Highlights

Gunilla Ho Slashedyer-Hansen is affiliated with Cancerforskningsfonden Af 1989, where her research focuses on the implications of u-PAR in cancer biology. Throughout her career, she has developed methods and techniques that contribute to the understanding of proteolytic activity in tumors and the potential to control metastasis.

Collaborations

Gunilla has collaborated with notable researchers, including Keld Dano Slashed and Ebbe Ro Slashednne. These partnerships have facilitated advancements in research methodologies and fostered a collaborative environment for innovative cancer research.

Conclusion

Gunilla Ho Slashedyer-Hansen exemplifies the essential role of inventors in the field of medical research. Her innovative patent on antibodies targeting u-PAR highlights her contributions to cancer diagnostics and therapeutics. Through her work, she continues to inspire future advancements in the fight against cancer.